ABVC
ABVC BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.91
−0.86%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$0.40
- Revenue estimate
- $113.3K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.03
- EPS estimate
- -$0.40
- Revenue actual
- —
- Revenue estimate
- $113.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +1.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.40 | -$0.03 | Beat 92.50% | — |
| May 18, 2026 | — | -$0.06 | — | — |
| Oct 31, 2025 | — | -$0.05 | — | $796.0K |
| Aug 13, 2025 | — | -$0.13 | — | — |
| Apr 30, 2025 | — | -$0.06 | — | — |
| Nov 14, 2024 | — | -$0.02 | — | $389.3K |
| Aug 14, 2024 | — | -$0.09 | — | $117.1K |
| May 17, 2024 | — | -$0.40 | — | $1.2K |
| Mar 13, 2024 | -$0.50 | -$0.35 | Beat 30.00% | $2.2K |
| Nov 15, 2023 | -$0.40 | -$0.82 | Miss -105.00% | $15.9K |
| Aug 14, 2023 | -$0.60 | -$0.68 | Miss -13.33% | $6.1K |
| May 15, 2023 | -$0.50 | -$0.60 | Miss -20.00% | $128.3K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026